Maya joined Gresham House in September 2019, and focuses on healthcare investments, including Orri, Metrion Biosciences and Panthera Biopartners.

Prior to Gresham House, she spent 4 years at Octopus Investments, investing in real estate-backed healthcare companies and entrepreneurs. Before this she worked at KPMG for 7 years in audit and corporate finance.

Maya holds a first-class degree in Modern History and is a Chartered Accountant (ICAEW).

Outside of work, Maya enjoys playing hockey (when not suffering from an injury!), travelling and watching martial arts films.

It’s a pleasure to be investing in the future of UK healthcare across a range of sub sectors and working with some of the country’s top scientists and clinicians to deliver world-class solutions.

Example portfolio

James joined Gresham House Ventures as Investment Manager in December 2019, before being promoted to Associate Director in 2022.

He is primarily focused on making new investments into fast growing software businesses focused on process automation, data and analytics or cyber security. He led GHV’s investment into Fu3e and also sits on the board of SecureCloud+.

I enjoy identifying and working with management teams who are solving large existing problems in a pragmatic way, balancing strategic vision alongside day-to-day execution.

Prior to joining GHV, he spent five years at PwC, latterly working in the financial due diligence team. He is a Chartered Accountant (ICAEW) and holds an MA in Economics and Accounting.

Outside of work James enjoys most sports, in particular golf, football and rugby.

Example portfolio